Fuca G, Guarini V, Antoniotti C, Morano F, et al. The Pan-Immune-Inflammation Value is a new prognostic biomarker in metastatic colorectal cancer: results from a pooled-analysis of the Valentino and TRIBE first-line trials. Br J Cancer 2020 May 19. pii: 10.1038/s41416-020-0894.
PMID: 32424148